A blaze has erupted at the site of the world’s largest coronavirus vaccine manufacturer. The site is producing millions of doses of the Covishield Covid vaccine, developed by AstraZeneca and Oxford University.
It is not known what caused the fire or whether anyone is injured (Picture: AP)
A blaze has erupted at the site of the world’s largest coronavirus vaccine manufacturer.
Huge plumes of smoke were seen billowing from Serum Institute of India (SII), in the western city of Pune today.
The site is producing millions of doses of the Covishield Covid vaccine, developed by AstraZeneca and Oxford University.
Local reports said that the blaze was at a construction site at the large facility.
A source at the institute said the production of the coronavirus vaccine will not be affected, but so far the company has declined to comment.
It comes shortly after India launched one of the biggest vaccine rollouts in the world (Picture: AP)
SII is manufacturing a vaccine developed by Oxford University and AstraZeneca for India and many other low- and middle-income countries.
The company is also getting ready to produce a vaccine being developed by the U.S. company Novavax Inc.
The fire office in Pune said five fire engines had been sent to the site. There was no immediate word on any casualties, nor on the cause of the fire.
This month Indian regulators approved two vaccines, Covishield, produced by the Serum Institute, and Covaxin, made by Bharat Biotech, based in Hyderabad.
Sources say production of the vaccine has not been affected, but the company is yet to comment (Picture: AP)
India launched one of the world’s largest vaccine rollouts on Saturday, with the aim of inoculating 300million people by July.
The country exported its first batch of the Covishield vaccine on Wednesday, to Bhutan and the Maldives.
It has also sent 2million doses to Bangladesh and 1million to Nepal.
India plans to offer 20million doses to neighbouring countries in South Asia, followed by Latin America, Africa and Central Asia.